Written and maintained by CASRAI Editorial Board
Last updated
A Health Canada Medical Device Licence (MDL) is the market authorization a device manufacturer needs before selling most medical devices in Canada — distinct from a Medical Device Establishment Licence (MDEL), which authorizes the business (manufacturer, importer, or distributor) rather than the device itself, and from MDALL (the Medical Devices Active Licence Listing), Health Canada’s public database of which devices currently hold one. The three terms get used almost interchangeably in casual conversation and are genuinely different things with different triggers, which is where most confusion about the Canadian pathway starts.
The Four Device Classes, and Which Licence Each One Needs
Health Canada classifies medical devices into four risk-based classes under the Medical Devices Regulations (SOR/98-282), made under the Food and Drugs Act — the single regulation that governs both conventional medical devices and in vitro diagnostic devices (IVDDs) in Canada, unlike the EU’s split between MDR and a separate IVDR. Classification follows a set of rules in Schedule 1 of the Regulations that weigh factors like invasiveness, duration of contact, and whether the device sustains or supports life:
- Class I — lowest risk (e.g., most surgical instruments, bandages). No device licence is required. The manufacturer, importer, or distributor placing the device on the Canadian market instead needs an MDEL.
- Class II — e.g., contact lenses, most in vitro diagnostic test kits for non-critical uses. Requires an MDL.
- Class III — e.g., orthopedic implants, infusion pumps. Requires an MDL, with a correspondingly higher evidentiary bar for safety and effectiveness.
- Class IV — highest risk (e.g., pacemakers, most implantable cardiac devices). Requires an MDL, with the most extensive clinical and manufacturing evidence expected of any class.
The practical rule of thumb: if a device is Class II, III, or IV, the device itself needs a licence (an MDL). Every business in the supply chain — manufacturers of any class, plus importers and distributors — separately needs an MDEL, covered below.
What an MDL Application Has to Include
Beyond the device-specific technical file (intended use, design specifications, risk analysis, labeling, and safety/effectiveness evidence scaled to class — bench and preclinical data for most Class II devices, clinical evidence expected more routinely as class rises), Health Canada’s licensing framework leans directly on the manufacturer’s quality management system certification. Since Health Canada moved from the earlier CMDCAS (Canadian Medical Devices Conformity Assessment System) recognition scheme to MDSAP, a current MDSAP certificate covering ISO 13485 (not a standalone, non-MDSAP ISO 13485 certificate) has been the accepted route for demonstrating QMS compliance for Class II, III, and IV licence applications and renewals — Health Canada was the first of the five MDSAP founding regulatory authorities to make the MDSAP certificate itself, rather than the older CMDCAS audit, the expected evidence. Re-verify the exact transition date directly against Health Canada’s current guidance before citing one in a compliance-critical context; this page deliberately doesn’t assert a specific day, the same caution CASRAI’s MDSAP guide applies to the same question.
MDALL: Checking Whether a Device Is Actually Licensed
MDALL (Medical Devices Active Licence Listing) is Health Canada’s own searchable public database of every device that currently holds an active MDL — searchable by device name, licence number, company name, or device class. It answers a specific, narrow question: is this device licensed for sale in Canada right now. It is not a full regulatory history: a device that has been licensed and later had its licence suspended, cancelled, or allowed to lapse drops out of the “active” listing rather than staying visible with a status flag, which is why procurement and compliance teams checking a device’s status should treat an MDALL search as a point-in-time confirmation, not an audit trail. For a fuller device history (amendments, past licence actions), Health Canada’s separate device-specific search tools and direct inquiry are the more complete route.
MDEL: The Other Half of the System
A Medical Device Establishment Licence authorizes a company — not a specific device — to manufacture, import, or distribute medical devices in Canada. It applies more broadly than the MDL: Class I manufacturers (who need no MDL at all) still need an MDEL, and importers/distributors of devices in any class need one regardless of whether the device itself already holds an MDL. A company selling a Class III device it did not manufacture, for example, needs its own MDEL even though the device’s MDL belongs to the manufacturer. Getting this distinction backward — assuming a device’s MDL alone clears every business in its supply chain to sell it — is one of the more common compliance gaps for companies newer to the Canadian market.
Keeping a Licence Current: Amendments and Post-Market Reporting
An MDL isn’t a one-time approval. A significant change to a licensed device — a design change affecting safety or effectiveness, a new manufacturing site, a new intended use, or a private-label version sold under a different name — typically requires a licence amendment before the changed device can be sold, not just a notification after the fact. Post-market, licence holders are subject to Mandatory Problem Reporting (MPR): manufacturers and importers must report device-related incidents (deaths, serious deterioration in health, and malfunctions that could plausibly cause one) to Health Canada within regulated timeframes, feeding into the same post-market surveillance obligations covered generally in CASRAI’s guide on post-market surveillance planning. A device recall or licence suspension is reflected as a status change removing the device from MDALL’s active listing.
How This Differs From the FDA and EU MDR Pathways
Two structural differences are worth knowing if a team is used to the FDA or EU framing: first, Canada regulates in vitro diagnostics under the same Medical Devices Regulations and the same class I-IV scheme as conventional devices, rather than carving IVDs into a separate regulation the way the EU’s IVDR does. Second, where FDA relies on its own direct inspection authority and the EU relies on independent notified bodies for conformity assessment, Health Canada’s licensing framework is built around accepting third-party MDSAP audit evidence for the QMS portion of the file rather than running a parallel Health-Canada-specific facility inspection for every applicant — which is also why the MDSAP certificate specifically, not a generic ISO 13485 certificate, is what Health Canada’s process actually asks for.
Frequently Asked Questions
Is MDSAP certification mandatory for a Health Canada medical device licence?
For Class II, III, and IV devices, yes — Health Canada expects an MDSAP certificate (not a standalone ISO 13485 certificate outside that program) as the accepted evidence of quality management system compliance for licensing and renewal. Class I devices don’t require an MDL at all, so this requirement doesn’t apply to them, though the establishment holding the MDEL is still expected to operate under a quality system appropriate to its activities.
Does every medical device sold in Canada need an MDL?
No. Class I devices are exempt from device licensing; only Class II, III, and IV devices require one. Every business in the supply chain (manufacturers, importers, distributors) separately needs an MDEL regardless of device class.
What exactly does MDALL show, and what does it not show?
MDALL shows devices with a currently active MDL, searchable by device name, licence number, company, or class. It does not function as a full historical record — a lapsed, cancelled, or suspended licence drops the device from the active listing rather than remaining visible with a status marker, so absence from MDALL doesn’t by itself tell you why a device isn’t there.
How is an in vitro diagnostic (IVD) regulated differently in Canada than a conventional device?
It generally isn’t, structurally — IVDs are classified and licensed under the same Medical Devices Regulations and the same Class I-IV scheme as conventional devices, rather than under a separate regulation the way the EU’s IVDR treats them.
